1. Mitomycin analogues I. Indolequinones as (potential) bisalkylating compounds;Oostveen;Tetrahedron,1987
2. Bioreductive drugs for cancer therapy: the search for tumor specificity;Adams;Int. J. Radiat. Oncol. Biol. Phys.,1994
3. Bioreductive drugs into the next millennium;Stratford;Anti-Cancer Drug Des.,1998
4. Wardman P, Dennis MF, Everett SA, Patel KB, Stratford MRL, Tracy M. Radicals from one-electron reduction of nitro compounds, aromatic N-oxides, and quinones: the kinetic basis for hypoxia-selective, bioreductive drugs. In: Rice-Evans C, Halliwell B, Lunt GG, editors. Free radicals and oxidative stress: environment, drugs and food additives (Biochemical Society Symposium No. 61). London: Portland Press, 1995. p. 171–94.
5. Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases;Beall;Cancer Res.,1994